NeuroSense Therapeutics Ltd. NRSN
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00% | -75.08% | 0.00% | -80.28% | |
| Total Receivables | 0.00% | -96.10% | 0.00% | 416.46% | |
| Inventory | 0.00% | -- | -- | -- | |
| Prepaid Expenses | 0.00% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 0.00% | 9.30% | 0.00% | 22.86% | |
| Total Current Assets | 0.00% | -50.00% | 0.00% | -64.65% | |
|
|
|||||
| Total Current Assets | 0.00% | -50.00% | 0.00% | -64.65% | |
| Net Property, Plant & Equipment | 0.00% | 117.14% | 0.00% | -30.00% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.00% | -4.35% | 0.00% | 0.00% | |
| Total Assets | 0.00% | -38.95% | 0.00% | -63.19% | |
|
|
|||||
| Total Accounts Payable | 0.00% | -26.90% | 0.00% | -5.78% | |
| Total Accrued Expenses | 0.00% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 0.00% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00% | -- | |
| Total Other Current Liabilities | -- | -- | 0.00% | -- | |
| Total Current Liabilities | 0.00% | 14.21% | 0.00% | 10.59% | |
|
|
|||||
| Total Current Liabilities | 0.00% | 14.21% | 0.00% | 10.59% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 0.00% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 0.00% | 17.48% | 0.00% | 10.59% | |
|
|
|||||
| Common Stock & APIC | 0.00% | 13.16% | 0.00% | 4.09% | |
| Retained Earnings | 0.00% | -15.51% | 0.00% | -12.85% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 0.00% | -200.58% | 0.00% | -120.09% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 0.00% | -200.58% | 0.00% | -120.09% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 0.00% | -200.58% | 0.00% | -120.09% | |
|
|
|||||